Norepinephrine ( DrugBank: Norepinephrine )
2 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 22 | Moyamoya disease | 2 |
| 296 | Biliary atresia | 1 |
22. Moyamoya disease
Clinical trials : 17 / Drugs : 22 - (DrugBank : 17) / Drug target genes : 33 - Drug target pathways : 45
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2000041260 | 2021-01-01 | 2020-12-23 | The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative hypotension in STA-MCA bypass surgery | The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative hypotension in STA-MCA bypass surgery | moyamoya disease | Group 1:iv norepinephrine;Group 2:iv phenylephrine; | The South District of Anhui Provincial Hospital | NULL | Recruiting | 18 | 65 | Both | Group 1:30;Group 2:30; | Phase 4 | China |
| 2 | ChiCTR2000029878 | 2020-11-01 | 2020-02-16 | The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative hypotension in STA-MCA bypass surgery | The effects of norepinephrine and phenylephrine on cerebral oxygenation in treating intraoperative hypotension in STA-MCA bypass surgery | moyamoya disease | Group 1:iv norepinephrine;Group 2:iv phenylephrine; | The South District of Anhui Provincial Hospital | NULL | Pending | 18 | 65 | Both | Group 1:30;Group 2:30; | Phase 4 | China |
296. Biliary atresia
Clinical trials : 71 / Drugs : 70 - (DrugBank : 39) / Drug target genes : 35 - Drug target pathways : 60
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05521152 (ClinicalTrials.gov) | May 1, 2022 | 28/8/2022 | Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy | Prophylactic Use of Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy Operation for Biliary Atresia: Double Blinded Randomized Controlled Trial | Anesthesia;Pediatrics;Biliary Atresia | Drug: Norepinephrine Bitartrate;Drug: Placebo | Kasr El Aini Hospital | NULL | Recruiting | 1 Month | 4 Months | All | 40 | Phase 3 | Egypt |